Regeneron Pharmaceuticals
Regeneron is seeking a Principal Scientist to join its Genetic Medicines team, focusing on preclinical development of targeted genetic medicines for central nervous system disorders. The role involves designing and leading experiments in CNS disease models, overseeing a team of associates, and communicating findings to senior leadership.
Headquarters
Tarrytown, New York, United States
Company Size
10001+ employees
Founded
1988
Discover how Regeneron (NASDAQ: REGN) harmonizes biology and technology to create life-changing medicines. Join our team and explore clinical trials.
Quadrant Capital Group LLC Purchases 1,564 Shares of Regeneron Pharmaceuticals, Inc. $REGN
4 hours ago
In 2036, Investors Will Regret Not Loading Up on This Multibagger in the Making
6 hours ago
Will Positive Obesity Data and Dupixent Expansion Efforts Change Regeneron Pharmaceuticals' (REGN) Narrative?
1 day ago
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Regeneron Pharmaceuticals.
23% above the average for this role
Regeneron: Fairly Valued Now After A Stellar Upswing (NASDAQ:REGN)
1 day ago
Principal Scientist II
Diversity Employment
Scientific Director | tRNA Biotherapeutics
Jobgether
Research Scientist in Pharmacology (Post-doctoral)
Galileo Global Education
Postdoctoral Research Scientist, Gene Therapy
Neurocrine Biosciences
Postdoctoral Scientist – Gene Therapy Biodistribution & Molecular Biology (CNS)
Eli Lilly and Company
Scientist
Eli Lilly and Company